How do I buy SI-BONE, Inc. Common Stock (SIBN) stock?

Buying SI-BONE, Inc. Common Stock (SIBN) stock is now easy and instant through the Gotrade app. Download the Gotrade app from the App Store or Google Play. Create an account and complete KYC. Make a deposit. Search for the code "SIBN", then tap "Trade". Tap the "Buy" button. Enter the amount you want to buy. You have two options: Buy SIBN by number of shares. Buy fractional shares in dollars, starting from $1. Swipe up to confirm your order, and you're done!

What is the minimum investment for SIBN on Gotrade?

On Gotrade, you don't have to buy a full lot. With fractional shares, you can start investing in SI-BONE, Inc. Common Stock from just $1. A small budget shouldn't stop you from building a US stock portfolio.

Does SI-BONE, Inc. Common Stock (SIBN) pay dividends?

At the moment, SI-BONE, Inc. Common Stock (SIBN) does not pay dividends because it focuses on reinvesting profits for company growth (a growth stock). However, you can still potentially earn profit from share price increases (capital gains). Track SIBN's performance via the price chart in the Gotrade app.

Is buying SIBN on Gotrade safe and legal?

Gotrade is the trading name of Gotrade Securities Inc., which is registered with and supervised by the Labuan Financial Services Authority (LFSA).

What are the market hours to buy SIBN?

You can place orders 24/7. Transactions will be executed when the US market (NYSE/NASDAQ) is open, from 9:30 PM to 4:00 AM WIB. Gotrade also provides access to pre-market and after-hours trading, so you have more flexibility and aren't limited to regular working hours. Market hours may change due to daylight saving time and holidays. In Gotrade, you can see the market status (open/closed) directly in the app.

How do I tell if SIBN is expensive or cheap?

There's no single perfect answer, but common approaches include: Compare valuation (e.g., P/E, P/S) against historical averages or competitors. Review revenue and earnings growth. Check margins and cash flow. Evaluate business outlook and the company's position within its industry. You can combine fundamental analysis with an investing strategy that matches your risk profile. All of the information above can be viewed directly in the Gotrade app.

SI-BONE, Inc. Common Stock (SIBN) Stock Price: Oct 12 Close $20.10

Name	Title	Year Born
Mr. Jeffrey W. Dunn	Executive Chairman	1956
Ms. Laura A. Francis MBA	CEO & Director	1967
Mr. Anshul Maheshwari	COO & CFO	1980
Mr. Michael A. Pisetsky J.D.	Chief Business & Legal Affairs Officer, Secretary and General Counsel	—
Mr. Anthony J. Recupero	Advisor	1960
Dr. Scott A. Yerby Ph.D.	Senior VP of Engineering & CTO	1968
Mr. Saqib Iqbal	Vice President of Financial Planning & Analysis and Investor Relations	—
Mr. Ian Bailey	Vice President of Product & Marketing	—
Dr. Daniel Joseph Cher M.D.	Senior Vice President of Clinical, Regulatory Affairs & Quality	1965
Dr. W. Carlton Reckling M.D.	Chief Medical Officer & VP of Medical Affairs	1963

	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
2021										-0.4	-17.1	+18.5
2022	-13.5	+11.4	+3.5	-12.1	-26.4	-9.2	-1.2	+20.2	+5.2	+11.5	-34.3	+7.3
2023	+27.9	+16.0	-1.7	+14.0	+11.4	+6.9	-5.6	-10.9	-6.1	-19.7	+9.8	+11.5
2024	-3.0	-15.9	-4.2	-9.6	-3.2	-9.5	+17.8	+12.0	-12.3	+1.3	+0.5	+4.9
2025	+20.3	+6.5	-20.1	-2.8	+38.2	-0.2	-7.0	-4.1	-10.5	+3.9	+29.3	+4.5
2026	-16.2	-5.2	-19.6	-4.8	+6.7	+17.7	+5.7	+3.1	-0.6	+9.2

SI-BONE, Inc. Common Stock (SIBN) Stock

Fundamentals

Compare with SIBN

Recent news

Si-Bone (SIBN) is a Great Momentum Stock: Should You Buy?

Si-Bone (SIBN) is a Great Momentum Stock: Should You Buy?

Wall Street Analysts Believe Si-Bone (SIBN) Could Rally 25.25%: Here's is How to Trade

Wall Street Analysts Believe Si-Bone (SIBN) Could Rally 25.25%: Here's is How to Trade

Does Si-Bone (SIBN) Have the Potential to Rally 38.58% as Wall Street Analysts Expect?

Does Si-Bone (SIBN) Have the Potential to Rally 38.58% as Wall Street Analysts Expect?

Si-Bone (SIBN) Reports Q2 Loss, Tops Revenue Estimates

Si-Bone (SIBN) Reports Q2 Loss, Tops Revenue Estimates

Technical indicators

Analyst ratings

Financials

Performance

Debt & Balance Sheet

Revenue to Profit

Earnings

Latest news

Si-Bone (SIBN) is a Great Momentum Stock: Should You Buy?

Si-Bone (SIBN) is a Great Momentum Stock: Should You Buy?

Wall Street Analysts Believe Si-Bone (SIBN) Could Rally 25.25%: Here's is How to Trade

Wall Street Analysts Believe Si-Bone (SIBN) Could Rally 25.25%: Here's is How to Trade

Does Si-Bone (SIBN) Have the Potential to Rally 38.58% as Wall Street Analysts Expect?

Does Si-Bone (SIBN) Have the Potential to Rally 38.58% as Wall Street Analysts Expect?

Si-Bone (SIBN) Reports Q2 Loss, Tops Revenue Estimates

Si-Bone (SIBN) Reports Q2 Loss, Tops Revenue Estimates

SiBone Q2 Earnings Call Highlights

SiBone Q2 Earnings Call Highlights

Bears are Losing Control Over Si-Bone (SIBN), Here's Why It's a 'Buy' Now

Bears are Losing Control Over Si-Bone (SIBN), Here's Why It's a 'Buy' Now

Wall Street Analysts Predict a 71.13% Upside in Si-Bone (SIBN): Here's What You Should Know

Wall Street Analysts Predict a 71.13% Upside in Si-Bone (SIBN): Here's What You Should Know

How Much Upside is Left in Si-Bone (SIBN)? Wall Street Analysts Think 65.27%

How Much Upside is Left in Si-Bone (SIBN)? Wall Street Analysts Think 65.27%

SiBone Q1 Earnings Call Highlights

SiBone Q1 Earnings Call Highlights

Si-Bone (SIBN) Reports Q1 Loss, Tops Revenue Estimates

Si-Bone (SIBN) Reports Q1 Loss, Tops Revenue Estimates

About SI-BONE, Inc. Common Stock

Key Executives

Fundamentals

Valuation

Earnings Per Share

Income Statement

Dividend

Technical indicators

Analyst views

Seasonality

Compare stocks

Market cap

Price / Earnings ratio

Price / Sales ratio

Dividend yield

Average volume

Earnings per share

Stocks in the same sector

FAQ

Trading Lebih Cepat. Lebih Mudah. Lebih Cerdas.

#ReadyGoTrade